Editas Medicine, Inc. (EDIT)
2.44
+0.02
(+0.83%)
USD |
NASDAQ |
Dec 09, 16:00
2.43
-0.01
(-0.41%)
After-Hours: 20:00
Editas Medicine Total Liabilities (Quarterly): 188.30M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 137.50M |
| Arcutis Biotherapeutics, Inc. | 212.90M |
| Daré Bioscience, Inc. | 27.89M |
| Cogent Biosciences, Inc. | 123.47M |
| Janux Therapeutics, Inc. | 48.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 201.75M |
| Shareholders Equity (Quarterly) | 13.45M |
| Debt to Equity Ratio | 5.852 |
| Current Ratio | 2.864 |
| Net Debt Paydown Yield | -2.47% |